BTG acquires chemical tool to ease surgery:
This article was originally published in Clinica
Executive Summary
UK firm BTG has acquired the rights to a new surgical tool that allows tissue to be cut much more easily. Developed for surgery by researchers at the University of Parma, Italy, MESNA (sodium-2-mercaptoethane sulphate) is a chemical dissection agent that breaks molecular bonds in tissues, allowing cancerous and normal tissue to be separated more easily. It has currently only been trialled in animals, where it was found to be effective in preventing and treating capsular formation in plastic surgery and reducing trauma to the tissue. The London- based firm said it would continue work to validate the tool.